Stable myocardial-specific lenti-S100A1 gene therapy results in heart failure after myocardial infarction rescue

摘要：

Background The incidence of heart failure after myocardial infarction is ever-growing,and it is urgent to develop improved treatments.An attractive approach is gene therapy;however,the clinical barrier has yet to be broken because of several issues,including the lack of an ideal vector supporting safe and long-term myocardial transgene expression.

作者: Xuewen Wang Zhiming Zhu

作者单位: Navy General Hospital Cardiology Division of PLA,Beijing 100061,China

会议类型: 国内会议

会议名称: 第14届中国南方国际心血管病学术会议

会议地点: 广州

会议语种:英文

页码: 135-135

在线出版日期: 2012-04-11（万方平台首次上网日期，不代表论文的发表时间）